¼¼°èÀÇ PLGA ½ÃÀå : Á¶¼ºº°, ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
PLGA Market, By Composition, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1477099
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 269 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,589,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,565,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,977,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

PLGA ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 1¾ï 2,324¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í 2024-2032³â¿¡ °ÉÃÄ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 15.5%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

PLGA ½ÃÀå : ½ÃÀå ¿ªÇÐ

¾à¹°Àü´Þ ¿ëµµ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °ßÀÎ

¾à¹°Àü´Þ ¿ëµµÀÇ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿¬±¸ÀÚµéÀº º¸´Ù ¾ÈÀüÇϰí È¿À²ÀûÀÎ ±â¼úÀ» ¸ð»öÇϰí ÀÖ½À´Ï´Ù. PLGA ³ª³ëÀÔÀÚÀÇ »ç¿ëÀº Ä¡·á·Î¼­ À¯¸Á½ÃµË´Ï´Ù. PLGA ³ª³ëÀÔÀÚ´Â ÀÎü¿¡ ¾ÈÀüÇÏ°í »ýºÐÇØ¼ºÀ̹ǷΠ¾à¹° Àü´Þ¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. Ç×¾ÏÁ¦ µî ´Ù¾çÇÑ ¾àÁ¦¸¦ ü³»ÀÇ ÀûÀýÇÑ Àå¼Ò·Î ¿î¹ÝÇϴµ¥ À¯¿ëÇÏ´Ù´Â °ÍÀÌ Áõ¸íµÇ¾ú½À´Ï´Ù. ¾à¹° Àü´ÞÀº º¹ÀâÇϱ⠶§¹®¿¡ ¸ðµç ¾à¹° À¯Çü, Åõ¿© °æ·Î ¹× Åõ¿© ºÎÀ§¸¦ °í·ÁÇØ¾ß ÇÕ´Ï´Ù. PLGA ³ª³ëÀÔÀÚ´Â ÀûÀÀ¼ºÀÌ ³ôÀº Ư¼ºÀ¸·ÎºÎÅÍ ÁÁÀº ¼±ÅÃÀÔ´Ï´Ù. ½Ã°£ÀÌ Áö³²¿¡ µû¶ó ¾à¹° ¹æÃâÀ» Á¦¾îÇϰí ÀûÀýÇÑ ºÎÀ§¿¡ µµ´ÞÇϵµ·Ï Å©±â¸¦ º¯°æÇÏ´Â ´É·ÂÀº ¹Ý°¨±âÀÇ ÂªÀº ¾à¹°°ú ÀÏÁ¤ÇÑ ¾à¹° ¼öÁØÀ» º¸ÀåÇÏ´Â Áß¿äÇÑ Æ¯Â¡ÀÔ´Ï´Ù. ±× °á°ú ¿¹Ãø±â°£ µ¿¾È ½ÃÀåÀº Å©°Ô È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

PLGA ½ÃÀå : ÁÖ¿ä ÀλçÀÌÆ®

¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â)¿¡ ¾à 15.5%ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

ÄÄÆ÷Áö¼Ç ¼¼ºÐÈ­ º°·Î, PLGA 50:50 ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë ¼öÀÍ Á¡À¯À²À» ȹµæÇÒ Àü¸ÁÀÔ´Ï´Ù.

¿ëµµº°·Î´Â ¾à¹°Àü´Þ ºÎ¹®ÀÌ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀ» µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ¿¹Ãø±â°£¿¡ ½ÃÀåÀ» µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹»ó

PLGA ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è PLGA ½ÃÀåÀº ±¸¼º, ¿ëµµ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

±¸¼º¿¡ µû¶ó PLGA ½ÃÀåÀº PLGA 50:50, PLGA 55:45, PLGA 65:35, PLGA 75:25, PLGA 85:15·Î À̺е˴ϴÙ. PLGA 50:50 ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë ¼öÀÍ °øÀ¯¸¦ ȹµæÇÒ Àü¸ÁÀÔ´Ï´Ù. PLGA 50:50ÀÇ ¿ëµµ´Â ¾à¹° Åõ¿©¿Í Á¶Á÷ °øÇÐÀ» Æ÷ÇÔÇÕ´Ï´Ù. ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ´Â ÀÌÀ¯´Â ¿©·¯ »ê¾÷¿¡ Àû¿ëµÇ°í Àç·á ¼º´É°ú ºÐÇØ ¿ªÇÐÀÇ ±ÕÇüÀ» ¸ÂÃá Ç¥ÁØ PLGA Á¶¼ºÀÌ ÇÊ¿äÇϱ⠶§¹®ÀÔ´Ï´Ù.

¿ëµµ¿¡ µû¶ó ¼¼°è PLGA ½ÃÀåÀº °ñÀý °íÁ¤, ÀÇ·á¿ë ÀÓÇöõÆ®, Ä¡°ú, ¾à¹° Àü´Þ, È­Àåǰ ¹× ÇǺΰú µîÀ¸·Î ±¸ºÐµË´Ï´Ù. ¾à¹°Àü´Þ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀ» µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Æú¸®À¯»ê °Ö(PLGA)À» ±â¹ÝÀ¸·Î ÇÑ ¾à¹° Àü´Þ ½Ã½ºÅÛÀº °¨¿°, ÁßÃß ½Å°æ Àå¾Ö, ½ÉÇ÷°ü Áúȯ, Á¾¾çÇÐ µî ¿©·¯ Ä¡·á ¿µ¿ª¿¡¼­ ÀÀ¿ëµË´Ï´Ù. Çʸ§, ³ª³ë ÀÔÀÚ, ¸¶ÀÌÅ©·Î ½ºÇǾî, ÀÓÇöõÆ®·Î Çü¼ºÇÏ¿© ´Ù¾çÇÑ ¾à¹°Àü´Þ ¿É¼ÇÀ» ¼³¸íÇÕ´Ï´Ù.

PLGA ½ÃÀå : Áö¸®Àû ÀλçÀÌÆ®

Áö¸®ÀûÀ¸·Î´Â ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °¢ Áö¿ª¿¡ ÆÛÁ® ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ Àü°³ÇÏ´Â ±¹°¡¿¡ µû¶ó ´õ ³ª´¹´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â ½ÃÀåÀ» µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ÀÇ·á ºÎ¹®ÀÇ ±Þ¼ºÀå, ÀÇ·á ½ÃÀå °³Ã´ ÀÌ´Ï¼ÅÆ¼ºê¿¡ÀÇ Á¤ºÎ ÁöÃâÀÇ ¸¹À½, ÀÌ Áö¿ª¿¡ÀÇ ´ë±â¾÷ÀÇ ÁýÁßÀÌ, ºÏ¹Ì ½ÃÀåÀÇ ¼öÀÍ ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ È­Çлê¾÷ Áõ°¡µµ ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

PLGA ½ÃÀå : °æÀï ±¸µµ:

½ÃÀå¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷Àº Corbion NV, Evonik, Jinan Digang Bioengineering Co.Ltd., Mitsui Chemicals, Akina, Inc., Nomisma Healthcare Pvt.Ltd., Merck, Ashland, Bezwada Biomedical, LLC, CD BioparticlesÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÁøÃâ±â¾÷Àº Á¦Ç° Ãâ½Ã, Àμö, Á¦ÈÞ µîÀ» Æ÷ÇÔÇÑ ¾÷°èÀÇ ÁÖ¿ä ½ÃÀå Á¡À¯À²À» ¾ò±â À§ÇØ ´Ù¾çÇÑ Àü·«À» äÅÃÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå PLGA ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå PLGAÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå PLGA ¾÷°è Á¶»ç

Á¦5Àå PLGA ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå PLGA ½ÃÀå »óȲ

Á¦7Àå PLGA ½ÃÀå : ±¸¼ºº°

Á¦8Àå PLGA ½ÃÀå :¿ëµµº°

Á¦9Àå PLGA ½ÃÀå :Áö¿ª

Á¦10Àå ÁÖ¿ä º¥´õ ºÐ¼®-PLGA ¾÷°è

Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

PLGA Market size was valued at USD 123.24 Million in 2023, expanding at a CAGR of 15.5% from 2024 to 2032.

The biodegradable polymer known as Poly(lactic-co-glycolic acid), or PLGA, is extensively employed in a range of biomedical applications. Both glycolic acid and lactic acid are naturally occurring substances that are copolymerized to create it. Because its mechanical strength, biocompatibility, and breakdown rate are all adjustable, PLGA is incredibly adaptable. Its biodegradability makes it appropriate for scaffolds used in tissue engineering, medical implants, and drug delivery systems, among other uses.

PLGA Market- Market Dynamics

Increasing demand for drug delivery applications drives market growth

The need for drug delivery applications is growing, which has prompted researchers to look for safer and more efficient techniques. The use of PLGA nanoparticles has shown promise as a remedy. Because they are safe for human use and biodegradable, they are an excellent choice for drug delivery. They have proven useful in getting different medications, such as anticancer medicines, to the right places in the body. The type of drug, the route of administration, and the intended area must all be taken into account due to the intricacy of drug delivery. Because of their adaptable characteristics, PLGA nanoparticles present a good option. Their ability to control drug release over time and to change their size to reach the appropriate site are important features for medications with short half-lives or for ensuring constant drug levels. As a result, during the forecast period, the global market is anticipated to increase significantly.

PLGA Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.5% over the forecast period (2024-2032)

Based on composition segmentation, the PLGA 50:50 segment is expected to capture the largest revenue share over the projected period

Based on application segmentation, the drug delivery segment is expected to dominate the market over the projected period

Based on region, North America is expected to dominate the market over the forecast period

PLGA Market- Segmentation Analysis:

The Global PLGA Market is segmented based on Composition, Application and Region.

Based on the composition, the PLGA market is bifurcated into PLGA 50:50, PLGA 55:45, PLGA 65:35, PLGA 75:25 and PLGA 85:15. The PLGA 50:50 segment is expected to capture the largest revenue share over the projected period. Medication administration and tissue engineering are two applications for PLGA 50:50. The market is growing because of the need for a standard PLGA composition that applies to multiple industries and strikes a balance between material performance and degradation kinetics.

Based on the application, the global PLGA market is segmented into Fracture Fixation, Medical Implants, Dentistry, Drug Delivery, Cosmetics and Dermatology and Miscellaneous. The Drug Delivery segment is expected to dominate the market over the projected period. Drug delivery systems based on polylactic acid gel (PLGA) find application in several therapeutic domains, including infectious diseases, central nervous system disorders, cardiovascular diseases, and oncology. They provide a variety of drug delivery options by being formed as films, nanoparticles, microspheres, or implants.

PLGA Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The rapidly growing healthcare sector in the region, significant government spending in healthcare development initiatives, and the concentration of large corporations in the region are the primary drivers of revenue growth in the North American market. In addition, the increase in the chemical industry would fuel the region's market revenue growth.

PLGA Market- Competitive Landscape:

The key players operating in the market are Corbion NV, Evonik, Jinan Digang Bioengineering Co., Ltd., Mitsui Chemicals, Akina, Inc., Nomisma Healthcare Pvt. Ltd., Merck, Ashland, Bezwada Biomedical, LLC and CD Bioparticles. These players adopted various strategies to gain major market share in the industry including product launches, acquisitions, collaboration and others.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLGA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Corbion NV

Evonik

Jinan Digang Bioengineering Co., Ltd.

Mitsui Chemicals

Akina, Inc.

Nomisma Healthcare Pvt. Ltd.

Merck, Ashland

Bezwada Biomedical, LLC

CD Bioparticles

GLOBAL PLGA MARKET, BY COMPOSITION- MARKET ANALYSIS, 2019 - 2032

GLOBAL PLGA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL PLGA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1.PLGA Market Overview

2.Executive Summary

3.PLGA Key Market Trends

4.PLGA Industry Study

5.PLGA Market: COVID-19 Impact Analysis

6.PLGA Market Landscape

7.PLGA Market - By Composition

8.PLGA Market - By Application

9.PLGA Market- By Geography

10.Key Vendor Analysis- PLGA Industry

11.360 Degree Analyst View

12.Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â